Effect of Evolocumab on Coronary Atherosclerosis

NCT03689946 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease
Hyperlipidemia

Interventions

DRUG: Evolocumab
DIAGNOSTIC_TEST: 18F-NaF PET
DIAGNOSTIC_TEST: CCTA
DRUG: Omnipaque
DRUG: Metoprolol
DRUG: Nitroglycerin

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]